Поисковый запрос: (<.>S=ВВЕДЕНИЕ ВНУТРЬ<.>) |
Общее количество найденных документов : 61
Показаны документы с 1 по 20
|
|
1.
| Evaluation of the humoral immune response of CD rats following a 2-week exposure to the pesticide carbaryl by the oral, dermal, or inhalation routes // G. Toxicol. and Environ. Health., 1994. Vol. 42, N 2.-С.143-156
|
2.
| Изучение тератогенности перголида мезилата при введении кроликам внутрь // Iyakuhin kenkyu, 1994. Vol. 25, N 2.-С.147-155
|
3.
| Cook Albert W. Improvement of motor function in multiple sclerosis by use of protopam chloride // Acupuncture and Elec.-Ther. Res., 1992. Vol. 17, N 4.-С.330
|
4.
| Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects // Neurobiol. Aging, 1992. Vol. 13, Suppl. n 1.-С.125
|
5.
| RS 42358-197, a novel and potent 5-HT[3] receptor antagonist, in vitro and in vivo // J. Pharmacol. and Exp. Ther., 1993. Vol. 266, N 2.-С.535-543
|
6.
| Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects // Neurobiol. Aging, 1992. Vol. 13, Suppl. n 1.-С.125
|
7.
| Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans // J. Pharmacol. and Exp. Ther., 1995. Vol. 272, N 1.-С.231-241
|
8.
| 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydrophyrrolo[2,3-f]indole: A novel 5-HT[2C]/5-HT[2B] receptor antagonist with improved affinity, selectivity, and oral activity // J. Med. Chem., 1995. Vol. 38, N 14.-С.2524-2530
|
9.
| Acute, subacute and chronic oral toxicity studies of the new serotonin (5-HT)[3]-receptor antagonist ramosetron in beagle dogs // Arzneim.-Forsch., 1995. Vol. 45, N 7.-С.760-766
|
10.
| Odensvik K. Pharmacokinetics of flunixin and its effect on prostaglandin F[2'альфа'] metabolite concentrations after oral and intravenous administration in heifers // J. Vet. Pharmacol. and Ther., 1995. Vol. 18, N 4.-С.254-259
|
11.
| Zhou Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated data // Biopharm. and Drug Dispos., 1995. Vol. 16, N 4.-С.319-331
|
12.
| Pharmacokinetics of superoxide dismutase in rats after oral administration // Biopharm. and Drug Dispos., 1996. Vol. 17, N 2.-С.165-174
|
13.
| Pharmacokinetics of superoxide dismutase in rats after oral administration // Biopharm. and Drug Dispos., 1996. Vol. 17, N 2.-С.165-174
|
14.
| Heiman Can we prevent diabetes? // Diabet. Forecast, 1996. Vol. 49, N 9.-С.25-27
|
15.
| Heiman Can we prevent diabetes? // Diabet. Forecast, 1996. Vol. 49, N 9.-С.25-27
|
16.
| Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats with alloxan-induced diabetes mellitus // J. Pharm. and Pharmacol., 1996. Vol. 48, N 10.-С.1093-1097
|
17.
| Bioavailability of boron in rats after single oral administration of sodium tetraborate // J. Trace Elem. Exp. Med., 1998. Vol. 11, N 4.-С.494
|
18.
| Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis // J. Pharmacol. and Exp. Ther., 1999. Vol. 289, N 1.-С.503-510
|
19.
| Flow controller configurations for an active agent delivery device
|
20.
| Flow controller configurations for an active agent delivery device
|
&uf('+1W2226#',v2226), ?>
|
|